Related Experiment Video
Updated: Jul 25, 2025

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
Published on: January 31, 2020
MOYAMOYA disease in an adolescent with HIV-1
Noella Maria Delia Pereira1, Yashwant R Gabhale1, Mamatha M Lala2
1Department of Pediatrics, Pediatric Centre of Excellence for HIV Care, LTMMC & GH, Mumbai, India.
Moyamoya disease, a rare cerebrovascular condition, is linked to human immunodeficiency virus type 1 (HIV-1) infection. This case highlights a pediatric patient with HIV-1 and Moyamoya disease, emphasizing the need for further research into their connection.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Moyamoya disease (MMD) is a rare, chronic cerebrovascular disease characterized by progressive stenosis of the intracranial arteries.
- MMD has been observed in patients with human immunodeficiency virus type 1 (HIV-1) infection, particularly in children.
- The exact etiology of MMD in HIV-1 patients remains unclear, with theories suggesting immune activation and cytokine imbalance.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Coronary Artery Disease III: Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology

